Cargando…
Epidermal growth factor (hEGF) has no effect on murine intestine epithelial damage and regeneration after melphalan.
The effect of epidermal growth factor (hEGF) on intestinal epithelial damage by melphalan was explored in CBA mice. Human EGF was administered in doses of 100 micrograms kg-1 or 1000 micrograms kg-1 using a variety of schedules. Mucosal damage was assessed 4, 8 and 13 days later, by [14C]-xylose upt...
Autores principales: | Robinson, B. A., Clutterbuck, R. D., Millar, J. L., McElwain, T. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977215/ https://www.ncbi.nlm.nih.gov/pubmed/3877517 |
Ejemplares similares
-
Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow.
por: Robinson, B. A., et al.
Publicado: (1985) -
Effects of verapamil and alcohol on blood flow, melphalan uptake and cytotoxicity, in murine fibrosarcomas and human melanoma xenografts.
por: Robinson, B. A., et al.
Publicado: (1986) -
Molecular Pharming of the Recombinant Protein hEGF-hEGF Concatenated with Oleosin Using Transgenic Arabidopsis
por: Qiang, Weidong, et al.
Publicado: (2020) -
Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy.
por: Selby, P. J., et al.
Publicado: (1987) -
Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.
por: Sweetenham, J. W., et al.
Publicado: (1990)